Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.54 |
| ▸ | MAOB | P27338 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 2/20 | 0.48 |
| ▸ | CHAT | P28329 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2033485 | 1.00 | NFE2L2 (0.54) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL3363528 | 0.89 | NFE2L2 (0.45) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL478036 | 0.87 | NFE2L2 (0.58) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL478037 | 0.87 | NFE2L2 (0.58) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL29360472 | 0.87 | TRPA1 (0.59) | NFE2L2TRPA1MAOBCHAT | |
| SCHEMBL41525 | 0.87 | TRPA1 (0.59) | NFE2L2TRPA1MAOBCHAT | |
| SCHEMBL3690347 | 0.87 | NFE2L2 (0.44) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL2301397 | 0.87 | NFE2L2 (0.44) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL41526 | 0.87 | TRPA1 (0.59) | NFE2L2TRPA1MAOBCHAT | |
| Ammonia Solution, Strong SCHEMBL7940805 | 0.85 | TRPA1 (0.57) | NFE2L2TRPA1MAOBCHAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10696620-B2 | Antimicrobial compounds | BOULOS & COOPER PHARMACEUTICALS PTY LTD (AU) | 2020-06-30 | — | — | US | disclosed |
| US-20180290963-A1 | ANTIMICROBIAL COMPOUNDS | BOULOS, RAMIZ (AU) | 2018-10-11 | — | — | US | disclosed |
| US-9738591-B2 | Antimicrobial compounds | Boulos, Ramiz (AU) | 2017-08-22 | — | — | US | disclosed |
| US-20170029359-A1 | ANTIMICROBIAL COMPOUNDS | THE UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2017-02-02 | — | — | US | disclosed |
| US-20150189873-A1 | ANTIMICROBIAL COMPOUNDS | BOULOS & COOPER PHARMACEUTICALS PTY LTD (AU) | 2015-07-09 | — | — | US | disclosed |
| US-9023892-B2 | Antimicrobial compounds | Boulos, Ramiz (AU) | 2015-05-05 | — | — | US | disclosed |
| US-20120329871-A1 | ANTIMICROBIAL COMPOUNDS | THE UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2012-12-27 | — | — | US | disclosed |
| WO-2011075766-A1 | ANTIMICROBIAL COMPOUNDS | THE UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2011-06-30 | — | — | WO | disclosed |
| CN-1268714-C | Organic electroluminescent material and electroluminescent device | RITDISPLAY CORP (CN) | 2006-08-09 | — | — | CN | disclosed |
| CN-1254459-C | Organic electroluminescent material and electroluminescent device | RITDISPLAY CORP (CN) | 2006-05-03 | — | — | CN | disclosed |
| US-7029764-B2 | Organic electroluminescent material and electroluminescent device by using the same | RITDISPLAY CORPORATION (TW) | 2006-04-18 | — | — | US | disclosed |
| US-7026061-B2 | Organic electroluminescent material and organic electroluminescent element by using the same | RITDISPLAY CORPORATION (TW) | 2006-04-11 | — | — | US | disclosed |
| US-20040183432-A1 | Organic electroluminescent material and organic electroluminescent element by using the same | RIT DISPLAY CORPORATION (TW) | 2004-09-23 | — | — | US | disclosed |
| US-20040146742-A1 | Organic electroluminescent material and electroluminescent device by using the same | RITDISPLAY CORPORATION (TW) | 2004-07-29 | — | — | US | disclosed |
| CN-1504531-A | Organic electroluminescent material and electroluminescent device | 铼宝科技股份有限公司 | 2004-06-16 | — | — | CN | disclosed |
| CN-1504532-A | Organic electroluminescent material and electroluminescent device | 铼宝科技股份有限公司 | 2004-06-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180290963-A1 | ANTIMICROBIAL COMPOUNDS | MRPL21, SPOUT1, MPO | NFE2L2 856/4885TRPA1 2242/4885MAOB 1409/4885 |
| US-10696620-B2 | Antimicrobial compounds | MRPL21, SPOUT1, MPO | NFE2L2 856/4885TRPA1 2242/4885MAOB 1409/4885 |
| US-20120329871-A1 | ANTIMICROBIAL COMPOUNDS | DPM1, NACA, CLPP | NFE2L2 1047/4885TRPA1 892/4885MAOB 2022/4885 |
| US-20170029359-A1 | ANTIMICROBIAL COMPOUNDS | MRPL21, SPOUT1, MPO | NFE2L2 856/4885TRPA1 2242/4885MAOB 1409/4885 |
| US-20150189873-A1 | ANTIMICROBIAL COMPOUNDS | DPM1, NACA, CLPP | NFE2L2 1047/4885TRPA1 892/4885MAOB 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.